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Introduction
Beta thalassemia intermedia (TI) is caused by a defective β -chain production resulting in marked α /β-globin chain imbalance 1 . This leads to a α -globin accumulation and RBC membrane damage determining anemia and intermittent blood transfusion. TI may result from a defective β-globin chains production due to β-globin gene defects, or from the increased production of α -globin chains, by a triplicate or quadruplicate α -genotype associated with β -thalassemia heterozygosity, the last situation leads to a milder form of TI [2] [3] [4] [5] . The excess of free α -chain has been demonstrated to precipitate within the erythroid precursors as hemichromes (HMC) forming large inclusion bodies 6 . In turn HMC alter the membrane clustering band 3 and enhancing the deposition of opsonin autologous immunogobulins and C3 fragments 7, 8 . Splenectomy, performed to alleviate anemia in TI patients, may result in severe thrombotic episodes 9, 10 and may cause a rise of pro-thrombotic circulating microparticles 11 (MPs) . In different diseases, such as ischemia, diabetes and atherosclerosis, the composition and the pathogenic roles of MPs have been extensively studied, revealing complex pathogenic roles modulating nitric oxide and prostacyclin production, stimulating cytokine release, inducing tissue factor expression, as well as monocyte chemotaxis and adherence to the endothelium [12] [13] [14] [15] [16] [17] [18] .
Recent findings on the mechanisms of redox regulation of the RBC membrane stability 19, 20 revealed that oxidative stress induces a phosphorylative response that specifically involves 2 tyrosine residues located in the cytoplasmic domain of band 3
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. Band 3 is the most abundant RBC membrane protein, and represents one of the major components of the junctional complexes that connect the lipid bilayer to the cytoskeleton.
We previously found that the oxidation of 2 cysteine residues in the band 3 cytoplasmic domain leads to the docking of Syk kinase. RBCs then appear to possess a mechanism able to recruit Syk kinase to a fraction of less glycosylated band 3 molecules capable of forming disulfide dimers 20 . In turn, phosphorylated band 3 molecules drastically decrease their affinity to ankyrin, increase their lateral mobility and the propensity to form large clusters inducing vesiculation 19 . In thalassemias, it has been previously demonstrated that HMC bind to band 3 causing free iron accumulation and free radical production 7, 21 , but their role in inducing band 3 phosphorylation and membrane destabilization has never been investigated. In the present report, we mainly investigated the role of HMC in the release of MPs from TI-RBCs. The comprehensive study of a group of TI patients with different genetic and clinical status, revealed new insights on the pathogenic role of circulating MPs and possible interventions to control their amount in thalassemia. .
Microparticle isolation
To induce MP release in vitro, RBCs from each volunteer and PHZ treated RBCs in PBS (30% hematocrit) were incubated as previously described 24 .
Electrophoresis and immunoblotting
Membrane and MP proteins were solubilized in Laemmli buffer 25 under reducing [2% (w/v) DTT (dithiothreitol)] or non-reducing conditions at a volume ratio of 1:1. SDS/PAGE was conducted and western blot analysis was performed using anti-phosphotyrosine (Santa Cruz, CA), anti-Band 3 and anti-IgG antibodies.
Mass Spectrometry analysis by MALDI-TOF
Protein bands were excised from gels, and prepared for MALDI-TOF analysis 26 .
Protein analysis by automated LC-MS/MS.
Gel slices containing the proteins were digested with trypsin.
Peptide mixtures were analyzed using microflow capillary liquid chromatography coupled with electrospray quadrupole time of flight tandem mass spectrometry (ESI Q-TOF MS/MS) 26 .
Preparation of cells for immunofluorescence
RBCs from each donor were fixed and permeabilized as previously described 27 .
Phagocytosis assay of Microparticles.
Phagocytosis assay and characterization of IgG mediated uptake was performed using a modification of a previously described method 28, 29 .
Measurement of band 3 clusters.
Membrane of TI-RBCs were prepared and fractionated using Sepharose CL-6B, as previously described 20 .
Results

Assessment of circulating MP counts and of the amount of MP released from erythrocytes in thalassemic patients
The number of circulating MPs derived from the red cell membranes has been measured in a group of TI patients. Table S1 shows the genetic and the hematological data of all patients included in our study. It should be evidenced that TI patients are genetically heterogeneous. Seventy five % of non splenectomized patients have α gene triplication with heterozigous β thalassemia while all the splenectomized patients are homozygous or compound heterozygous for β globin gene mutations. The latter patients have more severe globin chain unbalance than patients with alpha chain triplication.
Moreover, different β globin mutations have variable effects on β globin synthesis: β codon 39 causes a complete loss of β globin chain synthesis while IVS2-745 and IVS1-6 cause a partial reduction of β globin chain synthesis.
Additional differences are present in the series of patients studied especially related to the degree of iron overload and iron chelation. Table S2 shows MP counts and HMC levels in the same patients described in Table S1 .
In non-splenectomized TI patients we found a moderate increase in plasma MPs in comparison to control subjects, on the contrary, in splenectomized patients we found a marked increase in MP counts. We then estimated the capacity of the RBCs obtained from the same patients to release MPs. Fig. 1 , panels A-C shows a representative FACS analysis of MPs stained with a fluorescent anti-glycoforin antibody. Figure 1D demonstrates the positive correlation observed between the number of circulating MPs and the amount of MPs released from RBCs measured in each thalassemic patient (the correlation is significant only in splenoctomized patients). We also observed a correlation between the amount of released MPs and the concentration of HMC measured in the same TI-RBCs (Fig. 1E) . The finding that the concentration of HMC in patient's plasma correlated with the number of circulating MPs (Fig. 1F ), suggested that HMC may be functionally related to the process of MP release "in vivo". In parallel with the release of MPs, TI-RBCs subjected to mechanical stress also showed a measurable amount of hemolysis (1% in control RBCs, 2% in splenectomized RBCs and 4% in non-splenectomized RBCs). As a further indication of the association between circulating MPs and HMC, we found that the HMC present in TI plasma were pelletted together with the MPs following ultra-centrifugation of plasma. Interestingly, in splenectomized patients we observed a correlation between the number of circulating MPs and ferritin levels (r = 077, p < 0.01), the functional significance of this finding is unclear. Figure 1G shows that red cells from splenectomized TI patients contain clusters of HMC (Heinz bodies) that have been clearly evidenced by means of their natural fluorescent emission. Using confocal microscopy it was possible to observe that, in TI-RBCs from splenectomized patients, hemichromes show a marked tendency to protrude from the membrane surface (see arrows in Fig. 1G ). Red cells from non-splenectomized patients displayed less hemichrome inclusions and no protruding formations were observable (data not shown). Figure 1H shows MP isolated from TI-RBCs of splenectomized patients, hemichromes display similar size to that of the HMC observed in TI-RBCs (Fig. 1G) . The larger and variable size of MPs isolated from TI patients compared to those isolated from stored red cells 30 , could be due to the presence of HCM inclusions. Figure 1I displays the bright field of the same MPs shown in figure 1H , indicating that a large percentage of MP released from TI-RBCs of splenectomized patients actually contain HMC. HMC have been also visualized in the MP fraction isolated from patient's plasma (data not shown).
Characterization of MP released from thalassemic erythrocytes
We have previously demonstrated that oxidation and phosphorylation of band 3 determine the uncoupling between the lipid bilayer and the cytoskeleton inducing membrane instability and vesiculation 19 . Moreover phosphorylation of band 3 has been already demonstrated to be increased in thalassemia, although its functional effects have not been investigated. Figure 2 , panels A and B, shows that oxidized and clustered band 3, in accordance with a previous report 20 , is strongly hyper-phosphorylated in splenectomized TI patients than in non-splenectomized patients. Figure 2C shows that the amount of MP released from TIRBCs strictly correlates with the level of band 3 tyrosine phosphorylation (correlation are both significant in splenectomised and non splenectomized patients). In figure 2, panels D and E, is shown that Syk inhibitors determined a significant decrease of band 3 phosphorylation and a parallel reduction of the number of released MPs. we were able to observe resolved protein patterns. The efficiency of surface bound IgGs to opsonize MPs and to induce their phagocytosis was tested co-incubating MPs with human monocytes. Figure 3C shows the rate of MP ingestion indicating an half life of only 12 minutes. The direct effect of IgG opsonization on MPs phagocytosis was tested blocking the macrophage IgG receptors.
Characterization of the mechanism of microparticle release from TI-RBCs
To ascertain the role of hemichromes in the release of MPs, we treated normal RBCs with increasing amounts of phenylhydrazine (PHZ) to induce the formation of hemichromes through the specific oxidation of hemoglobin (Hb) and we then measured: HMC concentrations (Fig. 4A) , counts of released MPs (Fig.   4B ), levels of band 3 oxidation (Fig. 4C) , band 3 phosphorylation (Fig. 4D) , and band 3 clusterization (Fig.   4E ). To exclude a direct oxidative effect of PHZ on band 3, we treated isolated membranes with PHZ ( Fig   4F) . Fig 3A, lane 2) . This similarity has been confirmed by mass spectrometry analysis (Table 1 ). Figure 5 shows a schematic representation of the mechanism of the release of MPs driven by hemichromes. 10, 12, 36, 39, 40 . MPs originating from RBC membranes have been also considered a major cause of premature atherosclerosis described in thalassemia intermedia patients Following α or β globin oxidation, unstable HMC are formed and bind to the RBC membrane 41, 42, 43 . HMC are redox active and release free iron to the membrane 21 , the generation of free radicals may be then responsible for the formation of disulfide bonds between adjacent band 3 cytoplasmic domains 7 . This last phenomenon is conceivable with the fact that the cytoplasmic domain of band 3 represents the major binding site of HMC to the membrane and that band 3 cytoplasmic domain contains two relatively accessible cysteine residues 44, 45 . In particular, we showed that cysteine oxidation involves a distinct fraction of band 3 molecules that has been described to be less-glycosylated and shows higher susceptibility to be oxidized and then phosphorylated by Syk kinase
Discussion
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. In turn, phosphorylation of Tyr 8 and 21 residues placed at the Nterminal of band 3 determines its uncoupling from the cytoskeleton and markedly increases its lateral mobility leading to increased propensity to form clusters, to be easily extracted from the membrane and to induce membrane vesiculation 19, 46 .
A number of findings indicate that this mechanism may take place in the generation of MPs in TI-patients: i) Notably, the proteomic analysis of MPs also revealed the presence of two plasma proteins: transferrin and IgG. We have no clue to understand the binding of transferrin to MPs but its significance could be related to the trapping and detoxification of iron, that may be liberated from HMC 21 .As a matter of facts TI-RBC membranes have been demonstrated to contain measurable amounts of free iron that has been found to be highly concentrated in the membrane areas containing band 3/HMC aggregates 21 eliciting oxidative damage.
In the present study, we collected some results suggesting that the HMC contained in circulating MPs could be related to the alterations of iron compartmentalization and metabolism found in TI patients: considering the heme content of the HMC present in MPs (up to 20 nMoles/ml in splenectomized TI-patients), the amount of iron that is transported in MPs could be considerably high. Interestingly, in splenectomized patients we also observed a correlation between the number of circulating MPs and ferritin levels (r = 077, p < 0.01) possibly caused by the iron overload of non-splenic macrophages. Additional study on iron metabolism and compartmentalization should be required to investigate the functional correlations occurring between the iron transported in MPs and the complex alterations of iron homeostasis in thalassemias. Morphological evidences of "pitting" or "culling" of hemichromes by spleen macrophages has been previously provided 48, 49 . On the other hand, the elimination of HMC in the bone marrow has been previously hypothesized in β-thalassemia 6 and the loss of HMC through the vesiculation of specific membrane areas may play an important role in this phenomenon. 
Proteins were separated by 8% SDS-PAGE and analyzed by western blotting using anti-phosphotyrosine (αpTyr) (A) and anti-band 3 (B) antibodies. Images were acquired using a laser IR fluorescence detector (Odyssey, Licor, USA). Results are representative of 6-8 separated experiments for each group of patients. (C) Correlation between the amount of phosphorylation of band 3 in tyrosine residues (Bd3 tyr-phosphorylation) in TI-
.). (A) Hemichromes (HMC) contained in RBCs (nMoles/ml). (B) MPs released from RBCs (MPs x 10 3 /ml). (C) Amount of oxidized band 3 (au). (D) Levels of band 3 tyrosine phosphorylation (au). (E)Percentage of clustered band 3. (F) Amount of oxidized band 3 following isolated membrane incubation with increasing concentration of PHZ (au
Microparticle (MP) isolation
To induce MP release in vitro, RBCs from each volunteer and PHZ treated RBCs in PBS (30% hematocrit)
were incubated at 42°C for 45 minutes under stirring at 1400 rpm in a microtube and the supernatants were collected and centrifuged at 25,000xg for 10 min at 4°C to eliminate spontaneously formed red cell ghosts.
Supernatants, after addition of phosphatase inhibitors, were centrifuged for 3 hours at 100,000 x g on an ultracentrifuge (Beckman) at 4°C to isolate MPs.
Electrophoresis and immunoblotting
Membrane and MP proteins were solubilized in Laemmli buffer under reducing [2% (w/v) DTT (dithiothreitol)] or non-reducing conditions at a volume ratio of 1:1. SDS/PAGE was conducted by heating the samples for 5 min at 95 °C and loading on an 8% gel for protein staining by colloidal Coomassie Blue.
For Western blot analysis, proteins, separated by 8 % of SDS-Page, were transferred to nitrocellulose filters and probed with anti-band 3 antibody diluted 1:50000, anti-phosphotyrosine (Santa Cruz Biotechnology, CA), diluted 1:2000. Secondary antibodies, anti-mouse diluted 1:50000, conjugated to infrared fluorescent dyes excitable at 700/800 nm (IRDye 700/800CW, Li-COR-USA) were then used to visualize the desired antigens using an 700/800 nm laser scanner (Odyssey). Quantitative densitometry analysis was performed using Odyssey V3.0 software. For anti-IgG western blot, nitrocellulose membranes were immunostained with anti-human IgG antibody, alkaline phosphatase coniugated, diluted 1:10000, and detected using a chromogenic substrate BCIP /NBT Blue. Images were acquired using a Panasonic scanner KX-MB2010.
Mass Spectrometry analysis by MALDI-TOF
Protein bands were excised from gels, and prepared for MALDI-TOF analysis. MS analysis was performed with a MALDI-TOF micro MX (Micromass, Manchester, UK) according to the tuning procedures recommended by the manufacturer. Peak lists generated with Proteinlynx Data Preparation, were sent to MASCOT PMF search (http://www.matrixscience.com) using a Swiss-Prot database (release 50.0, May 30, 2006) .Only protein identifications with significant MASCOT scores (p<0.05) were considered as relevant for our analysis.
Protein analysis by automated LC-MS/MS.
Gel slices containing the proteins were digested with trypsin as described in the previous section. Peptide 
Preparation of cells for immunofluorescence
RBCs from each donor were fixed and permeabilized as previously described 27 . RBCs and MPs were suspended in PBS and allowed to attach to cover slips coated with polylysine, and the cover slips were mounted by using Aqua-Mount (Lerner Laboratories, New Haven, CT). The auto-fluorescence of hemichromes was visualized by exciting at 488 nm and observing their emission in the 630-750 nm range.
Samples were imaged with a Leica TCS SP5 X (Leica Microsystems, Germany) confocal microscope equipped with a 6061.4 numerical aperture oil immersion lens.
Phagocytosis assay of MPs.
Phagocytosis assay and characterization of IgG mediated uptake was performed using a modification of a previously described method 28,29, . MPs isolated from TI-patients plasma have been incubated in suspension with human monocytes, the number of phagocytized MPs has been quantified measuring the amount of ingested heme by a chemiluminescence technique.
Determination of serum iron
Iron was measured by a standard colorimetric method by Beckman, Synchron LX20 . Tables   Table S1 , Clinical data. Normal (Ctrl), non splenectomized TI (TI) and splenectomized TI (TI Spl) subjects analyzed in the present study, listed with genetic and clinical data. Table S2 , Experimental data. Normal (Ctrl), non splenectomized TI (TI) and splenectomized TI (TI Spl) subjects analyzed in the present study, listed with experimental data: hemichromes levels (HMC) and microparticle counts (MPs) in plasma of TI patients.
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